Learn more about our Regulatory Affairs work.
WASHINGTON, D.C.—AdvaMed, the Medtech Association, today expressed strong support for the draft Medical Device User Fee Amendments (MDUFA) VI agreement at an FDA public hearing.
Join Cooley LLP as they explore how to evaluate and strengthen your IP position, prepare for competitive challenges, and avoid common pitfalls that can undermine value during due diligence and…
Learn how to enter Japan’s medtech market with insights on regulatory pathways, consultation services, and practical insights for U.S. medtech companies.
Join Boston Consulting Group as they explore how medtech organizations are using AI to transform product development and accelerate innovation.
WASHINGTON, D.C.—AdvaMed, the Medtech Association, today welcomed next steps in the Medical Device User Fee Amendments reauthorization process following clearance by the White House Office of Management and Budget of…
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the largest trade association representing medtech innovators, posted his statement on LinkedIn regarding the nomination of Chris Klomp as deputy secretary of the…
Millions of Americans have the neurological condition essential tremor. Often, that means their hand shakes so badly, they can’t hold a pen, fork, or glass of water. Every activity of…
China GMP and ISO 13485: A Side-by-Side Comparison
Join Kearney as they explore how medtech organizations are using AI to transform product development and accelerate innovation.
Explore ASC growth trends, buyer dynamics & go-to-market strategies for medtech manufacturers in this webinar with Alexander Group.